Advagene Biopharma Co., Ltd.
6709.TWO
Taipei Exchange24.50
TWD
-0.65
- -
Total Valuation
Advagene Biopharma Co., Ltd. carries a market capitalization of 1.68B, placing it among publicly traded companies globally.
| Market Cap | 1.68B |
| Enterprise Value | N/A |
Stock Price Statistics
Advagene Biopharma Co., Ltd.'s stock has gained approximately 12.38532% over the past 52 weeks. The 50-day moving average sits at 25.40, while the 200-day moving average is 29.40.
| Beta (5Y) | N/A |
| 52-Week Price Change | 12.38532% |
| 50-Day Moving Average | 25.40 |
| 200-Day Moving Average | 29.40 |
| Average Volume (20 Days) | N/A |